First Time Loading...

Circassia Group PLC
LSE:CIR

Watchlist Manager
Circassia Group PLC Logo
Circassia Group PLC
LSE:CIR
Watchlist
Price: 36.5 GBX 0.83% Market Closed
Updated: May 8, 2024

Circassia Group PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Circassia Group PLC
Revenue Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Circassia Group PLC
LSE:CIR
Revenue
£31.3m
CAGR 3-Years
-3%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Revenue
$6.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Revenue
$1.7m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Revenue
$41.6m
CAGR 3-Years
55%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Revenue
£249.4m
CAGR 3-Years
102%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Revenue
£673.1m
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
6%

See Also

What is Circassia Group PLC's Revenue?
Revenue
31.3m GBP

Based on the financial report for Dec 31, 2022, Circassia Group PLC's Revenue amounts to 31.3m GBP.

What is Circassia Group PLC's Revenue growth rate?
Revenue CAGR 5Y
-8%

Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Circassia Group PLC have been -3% over the past three years , -8% over the past five years .